Clinical trial · Interventional
Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position
Minimally Invasive Esophagectomy in Prone or Left Decubitus Position: A Prospective Randomized Clinical Trial From A Single Institution
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this prospective randomized study is to compare clinical outcomes from two different patient position(prone vs left decubitus)with thoracoscopic esophageal mobilization in the procedure of Minimally Invasive Esophagectomy (MIE). * Comparing morbidities from the two groups * Comparing short-term quality of life from the two groups * Comparing oncological results (3,5 year survival) from the two groups
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Esophagectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| thoracoscopic esophagectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Perioperative morbidity and mortality from the two groups
- timeFrame
- 1 -5 years after surgery
Secondary outcomes (2)
- measure
- short-term quality of life(postoperative 6 months and 1 year) between the two groups
- timeFrame
- 1 year
- measure
- 3-and 5-year survival rate between the two groups
- timeFrame
- 1 - 5 years after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * clinical stage I/II esophageal cancer * normal blood test of basic metabolism panel * pulmonary function: FEV1 \> 1.2L, FEV1% \> 50%, DLCO \> 50% * heart function: NY grade I and grade II * sign informed consent Exclusion Criteria: * Patients who received neoadjuvant therapy * Mental disorders
References
Publications (0)
Data not yet available